These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 28849232

  • 1. Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer.
    Kong R, Liu W, Guo Y, Feng J, Cheng C, Zhang X, Ma Y, Li S, Jiang J, Zhang J, Qiao Z, Qin J, Lu T, He X.
    Oncol Rep; 2017 Oct; 38(4):2572-2580. PubMed ID: 28849232
    [Abstract] [Full Text] [Related]

  • 2. miR‑145 inhibits human non‑small-cell lung cancer growth by dual-targeting RIOK2 and NOB1.
    Liu K, Chen H, You Q, Ye Q, Wang F, Wang S, Zhang S, Yu K, Li W, Gu M.
    Int J Oncol; 2018 Jul; 53(1):257-265. PubMed ID: 29749434
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H, Kong J, Ding K, Shen HM, Wu H, Xia D, Wu Y.
    Mol Cancer; 2017 Jul 11; 16(1):118. PubMed ID: 28697764
    [Abstract] [Full Text] [Related]

  • 6. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer.
    Khandelwal A, Seam RK, Gupta M, Rana MK, Prakash H, Vasquez KM, Jain A.
    Cancer Sci; 2020 Mar 11; 111(3):826-839. PubMed ID: 31520555
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
    He X, Chen SY, Yang Z, Zhang J, Wang W, Liu MY, Niu Y, Wei XM, Li HM, Hu WN, Sun GG.
    J Exp Clin Cancer Res; 2018 Sep 18; 37(1):230. PubMed ID: 30227870
    [Abstract] [Full Text] [Related]

  • 10. MiR-93-5p up-regulation is involved in non-small cell lung cancer cells proliferation and migration and poor prognosis.
    Yang W, Bai J, Liu D, Wang S, Zhao N, Che R, Zhang H.
    Gene; 2018 Mar 20; 647():13-20. PubMed ID: 29309884
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MiR-34b-3p represses cell proliferation, cell cycle progression and cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting CDK4.
    Feng H, Ge F, Du L, Zhang Z, Liu D.
    J Cell Mol Med; 2019 Aug 20; 23(8):5282-5291. PubMed ID: 31199581
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CircRNA CDR1as knockdown inhibits progression of non-small-cell lung cancer by regulating miR-219a-5p/SOX5 axis.
    Li Y, Zhang J, Pan S, Zhou J, Diao X, Liu S.
    Thorac Cancer; 2020 Mar 20; 11(3):537-548. PubMed ID: 31917898
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MicroRNA-590-5p suppresses the proliferation and invasion of non-small cell lung cancer by regulating GAB1.
    Xu BB, Gu ZF, Ma M, Wang JY, Wang HN.
    Eur Rev Med Pharmacol Sci; 2018 Sep 20; 22(18):5954-5963. PubMed ID: 30280777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.